(1 - 19 from 24
)
Beau Wrigley Jr.'s Parallel to go public - Atlanta Business Chroniclewww.bizjournals.com › atlanta › news › › beau-wrigley-parall...
www.bizjournals.com
Feb 22, · Marina Bozilenko, strategic advisor to William Blair and Company. Dr. Kevin Douglas, medical director of U.S. Rheumatology and study ...
Fireside chat: What is really driving the value for Biopharma? - faccnefaccne.org › event › fireside-chat-what-is-really-driving-the-value-for-biop...
faccne.org
Nov 26, · The discussion will be driven by Marina Bozilenko Head of Biotech & Pharma, Managing Director, at William Blair & Company.
Announce: Novamedica on BIO 2013: Spotlight On The BRICs. Russia, Our...
rmi.com.ru
Moderator: Marina Bozilenko, Head of Biotechnology & Pharma, William Blair & Company, LLC. Speakers: Oleg Fomichev, Deputy Minister of Economic Development, Russia Igor Agamirzyan, CEO of Russian Venture Company Nikolay Savchuk, Director of the Center for Strategic Development, Moscow ...
Amylin gears for 3-way proxy fight as Carl Icahn names five nominees...
www.rttnews.com
The private investor, which holds 12.5% of the medical company, has named Kathleen Behrens, Marina Bozilenko, Charles Fleischman, ...
sorted by relevance / date